Neutralization of heparin activity

31Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Heparin is the mainstay in the treatment and prevention of thrombosis in such diverse clinical settings as venous thromboembolism, acute coronary syndrome, cardiopulmonary bypass, and hemodialysis. However, the major complication of heparin - like that of all anticoagulants - is bleeding. Heparin may need to be reversed in the following settings: clinically significant bleeding; prior to an invasive procedure; at the conclusion of a procedure involving extracorporeal circulation (e.g., cardiopulmonary bypass, dialysis). This chapter discusses protamine sulfate, as well as several other agents that are able to neutralize heparin, including their pharmacological properties, indications, dosing, and efficacy. © 2012 Springer-Verlag Berlin Heidelberg.

Cite

CITATION STYLE

APA

Pai, M., & Crowther, M. A. (2012). Neutralization of heparin activity. Handbook of Experimental Pharmacology, 207, 265–277. https://doi.org/10.1007/978-3-642-23056-1_11

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free